Who is affected by this change?

This affects Independence Blue Cross ENT (Ear, Nose & Throat) providers on Commercial plans.

When does this change take effect?

This change is effective Apr 2, 2025.

Back to dashboard

CommercialCoverageMedium impact

11.16.06k, Balloon Catheter Dilation of Sinus Ostia for Treatment of Chronic Rhinosinusitis or Recurrent Acute Rhinosinusitis

Independence Blue Cross·ENT (Ear, Nose & Throat)·Medical Policy

Effective date

Apr 2, 2025

We identified it

Jun 19, 2026

Days to comply

—

Summary

The policy for balloon catheter dilation of sinus ostia for chronic or recurrent acute rhinosinusitis has been reissued with an effective date of April 2, 2025. This is a commercial insurance policy update that may affect coverage criteria or billing requirements for this ENT procedure.

Action Required

Action needed

Before April 2, 2025: Billing team should review the updated policy details at the provided URL to identify any changes to coverage criteria, prior authorization requirements, or documentation needs for balloon catheter dilation procedures. Update billing protocols and provider documentation requirements accordingly.

Related policy hubs

Independence Blue Cross policies ENT (Ear, Nose & Throat)